Physician profile
Roy B Sauberman
NPI 1912948142
$9,432.49
in general payments reported to CMS, 2019-2025
24 companies · $254 in 2025
The $254 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,399 · 2020: $1,089 · 2021: $920 · 2022: $919 · 2023: $940 · 2024: $911 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,105.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,492.34 | 2019-2025 | Watchman Flx, Farapulse |
| Medtronic Vascular, INC. | $2,186.26 | 2019 | |
| Abbott Laboratories | $1,872.23 | 2019-2025 | Aveir, Jot Dx, Assurity |
| Biosense Webster, INC. | $929.36 | 2019-2025 | Carto 3, Qdot Micro, Octaray Mapping Catheter |
| Medtronic, INC. | $455.57 | 2022-2024 | Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan, Arctic Front Advance |
| Biotronik INC. | $418.73 | 2019-2024 | Biomonitor, Amvia Edge |
| Impulse Dynamics (USA) INC. | $289.05 | 2021-2023 | Optimizer |
| E.R. Squibb & Sons, L.L.C. | $121.03 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $120.04 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $76.42 | 2019-2022 | |
| Amgen INC. | $71.94 | 2019-2024 | Repatha |
| Pfizer INC. | $50.83 | 2019-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $49.51 | 2024 | Arcalyst |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $44.57 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $43.29 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $42.02 | 2024-2025 | Savvywire, Ensoetm |
| Tactile Systems Technology INC | $31.52 | 2020 | |
| Amarin Pharma, INC. | $29.71 | 2019 | |
| Sanofi-Aventis U.S. LLC | $28.62 | 2019-2023 | |
| Scpharmaceuticals INC. | $21.07 | 2024 | |
| Recor Medical INC | $15.60 | 2024 | Paradise Renal Denervation System |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.97 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Sauberman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.